Verastem, Inc. Long-Term Debt
Verastem, Inc. (VSTM) had Long-Term Debt of $21.54 million as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermDebtNoncurrent · last filed 2018-11-07
- 2018-09-30: Long-term Debt, Excluding Current Maturities $21.54M.
- 2018-06-30: Long-term Debt, Excluding Current Maturities $23.52M.
- 2018-03-31: Long-term Debt, Excluding Current Maturities $14.91M.
- 2017-12-31: Long-term Debt, Excluding Current Maturities $14.83M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2018-09-30 | $21.54M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $23.52M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $14.91M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $14.83M 10-Q · filed 2018-11-07 |
| 2017-09-30 | $2.33M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $2.29M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.25M 10-Q · filed 2017-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |